——
Level — · Streak —
— XP
Mastery—weighted
Quizzes 30d—last 30 days
Cert progress—active level
Rank—global
Loading...
The page behind this dialog is live. Create a free account or sign in and you'll land right back on it.
The most used — and misused — valuation metric
Price-to-Earnings is the most widely-quoted valuation multiple in finance. It answers a simple question: how many dollars do investors pay for each dollar of annual earnings? P/E of 20x means \$20 of stock price for every \$1 of EPS. The S&P 500's long-run average is roughly 18-20x; in extreme bull markets it has reached 30-35x; in crashes it has compressed to 10-13x. The metric is simple to compute and almost always available — and that simplicity is also why it's the most-misused valuation metric in finance. P/E in isolation tells you nothing useful; P/E in context tells you a lot.
= Share Price ÷ Earnings Per Share. Two flavors. uses actual last-12-months EPS — backward-looking but uses real numbers. uses analyst estimates of next-12-months EPS — forward-looking but depends on the accuracy of estimates (which are systematically optimistic on average). Both are useful; comparing trailing to forward P/E shows you whether earnings are expected to grow (forward < trailing) or contract (forward > trailing).
A P/E of 25 is cheap for a growing software company and expensive for a static utility. A P/E of 8 is reasonable for a stable consumer-staples business and absurdly cheap for a growth tech name (or possibly a value trap if earnings are about to collapse). The metric only tells you something useful relative to: (1) the same company's historical P/E, (2) industry peers' P/E, and (3) the company's growth rate (PEG). The empirical research on P/E factor investing (Fama-French value factor and successors) consistently shows that pure low-P/E strategies underperform quality-adjusted strategies — value traps absorb most of the cheap-multiple basket. Combine P/E with quality (the M4 scorecard) and growth (PEG), and the multiple becomes informative; use it alone, and it's barely better than random.
Three structural P/E traps. First: cyclical earnings at the peak. A cyclical company (steel, semiconductors, oil) at P/E 8 during a boom might be screaming-expensive if earnings are about to compress 60%, taking the multiple to 20x at the trough. Conversely, a cyclical at P/E 30 in a downturn might be cheap if earnings are about to recover 3-5x. Read industry cycle position, not just the multiple. Second: 'growth' P/E that depends on earnings the company hasn't yet earned. A pre-profit company at 100x trailing earnings might be reasonable if the trajectory supports it; a 50x company whose growth has decelerated to 10% is overpaying. Third: 'value' P/E that's a trap. Companies at 5-8x P/E with declining revenues and weak balance sheets are cheap because they're shrinking. Run the M4 quality scorecard before assuming low P/E means opportunity.
The same P/E means different things across sectors. Always compare within industry; cross-sector P/E comparison is mostly noise. These are reference levels, not current quotes.
In 2014, Apple's trailing P/E was around 13x — close to the broader market and well below growth-tech peers. The market was skeptical of Apple's prospects post-Steve Jobs and viewed it as a hardware company facing commoditization. Over the next decade, Apple expanded its services revenue (\$24B in 2017 → \$96B by FY2024), grew gross margins, and demonstrated durable pricing power. The P/E expanded from ~13x to ~30x — more than doubling — even as earnings themselves nearly tripled. The combination of P/E expansion AND earnings growth produced the ~10x stock return over the decade. The lesson: quality doesn't just earn a premium; the market sometimes catches on later than fundamentals warrant, and patient investors who buy at lower multiples capture both the earnings growth AND the multiple expansion. Cite: AAPL 10-K filings 2014-2024.
The Valuation tab on every stock page shows trailing P/E, forward P/E, and 10-year P/E history alongside peer-group comparison. The KPIs tab plots P/E over time so you can see whether the current multiple is at the high end, low end, or middle of the historical range. The /screener page lets you filter by P/E range AND by quality dimensions (ROIC, growth) — useful for finding low-multiple high-quality names. The Insights tab adds context on why current P/E differs from peers.
First: cyclical peaks. A 'cheap' cyclical at P/E 8 in a boom is often expensive at trough P/E 25 when earnings collapse. Use cycle-adjusted EPS (10-year average) for cyclicals. Second: low P/E quality cliffs. A company at 5x P/E with deteriorating fundamentals is cheap because it's shrinking; pure low-P/E without quality screen produces value traps consistently. Third: high-P/E growth that hasn't materialized. 100x P/E on optimistic forward estimates is extremely sensitive to growth assumptions; if growth disappoints, the multiple compression is brutal. Always pair P/E with the M4 quality scorecard and the m5 financial-health workflow before treating multiple as informative.
Price is what you pay; value is what you get. The price-to-earnings ratio is the most-quoted measure in finance and the least useful in isolation. Pair it with a thoughtful judgment about what the underlying business is actually worth — quality, durability, growth — and you have something meaningful. Use it as a single number and you have a value trap waiting to happen.